Schweneker, Katrin
Lenk, Miriam
Kern, Wolfgang
Haferlach, Claudia
Meggendorfer, Manja
Pohlkamp, Christian
Haferlach, Torsten
Article History
Received: 29 April 2025
Revised: 18 July 2025
Accepted: 28 July 2025
First Online: 4 September 2025
Declarations
:
: WK, CH and TH declare part ownership of Munich Leukemia Laboratory (MLL). KS, ML, MM, and CP are employed by the MLL Munich Leukemia Laboratory.
: All patients had given written informed consent for the use of genetic and clinical data in accordance with the Declaration of Helsinki. The study was approved by our internal institutional review board. This study contains only laboratory data from a large cohort of patients. No clinical trial was performed.